Bonds News
Wednesday, March 16, 2016
BRIEF-Helix Biopharma Q2 loss per share C$0.03
* Helix Biopharma Corp. announces second quarter fiscal 2016 results
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment